What is Amphastar Pharmaceuticals Operating Cash Flow per Share?
Amphastar Pharmaceuticals's operating cash flow per share for the
three
months ended in Mar. 2024 was $1.04.
Amphastar Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $3.72.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Amphastar Pharmaceuticals was 146.40% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 43.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 32.40% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Amphastar Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:
AMPH'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -40.6 Med: 17.3 Max: 51.2
Current: 43.7
During the past 13 years, Amphastar Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.20% per year. The lowest was -40.60% per year. And the median was 17.30% per year.
AMPH's 3-Year OCF Growth Rate is ranked better than 85.71% of 805
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs AMPH: 43.70
Amphastar Pharmaceuticals Operating Cash Flow per Share Historical Data
The historical data trend for Amphastar Pharmaceuticals's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Amphastar Pharmaceuticals Operating Cash Flow per Share Chart
Competitive Comparison of Amphastar Pharmaceuticals's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Amphastar Pharmaceuticals Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Amphastar Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.72
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amphastar Pharmaceuticals Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Business Description
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMPH has been successfully added to your 